262 related articles for article (PubMed ID: 34158842)
21. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme.
Napier TS; Udayakumar N; Jani AH; Hartman YE; Houson HA; Moore L; Amm HM; van den Berg NS; Sorace AG; Warram JM
Mol Cancer Ther; 2020 Sep; 19(9):1922-1929. PubMed ID: 32606015
[TBL] [Abstract][Full Text] [Related]
23. Near-Infrared Fluorescent Peptides with High Tumor Selectivity: Novel Probes for Image-Guided Surgical Resection of Orthotopic Glioma.
Liu Y; Wang Z; Li X; Ma X; Wang S; Kang F; Yang W; Ma W; Wang J
Mol Pharm; 2019 Jan; 16(1):108-117. PubMed ID: 30517013
[TBL] [Abstract][Full Text] [Related]
24. Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.
Lwin TM; Hoffman RM; Bouvet M
J Surg Oncol; 2018 Aug; 118(2):253-264. PubMed ID: 30080930
[TBL] [Abstract][Full Text] [Related]
25. Improved surgical resection of metastatic pancreatic cancer using uPAR targeted
Juhl K; Christensen A; Rubek N; Karnov KKS; von Buchwald C; Kjaer A
Oncotarget; 2019 Oct; 10(59):6308-6316. PubMed ID: 31695839
[TBL] [Abstract][Full Text] [Related]
26. Preclinical assessment of IRDye800CW-labeled gastrin-releasing peptide receptor-targeting peptide for near infrared-II imaging of brain malignancies.
Zhang Y; Wang L; Zhang C; Zhang J; Yuan L; Jin S; Zhou W; Guan X; Kang P; Zhang C; Tian J; Chen X; Li D; Jia W
Bioeng Transl Med; 2023 Jul; 8(4):e10532. PubMed ID: 37476052
[TBL] [Abstract][Full Text] [Related]
27. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
Persson M; Rasmussen P; Madsen J; Ploug M; Kjaer A
Nucl Med Biol; 2012 Oct; 39(7):962-9. PubMed ID: 22739362
[TBL] [Abstract][Full Text] [Related]
28. Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
Ni XR; Zhao YY; Cai HP; Yu ZH; Wang J; Chen FR; Yu YJ; Feng GK; Chen ZP
J Neurooncol; 2020 Jun; 148(2):245-258. PubMed ID: 32405996
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
30. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
[TBL] [Abstract][Full Text] [Related]
31. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.
Gilder AS; Jones KA; Hu J; Wang L; Chen CC; Carter BS; Gonias SL
J Biol Chem; 2015 Jun; 290(24):14798-809. PubMed ID: 25837250
[TBL] [Abstract][Full Text] [Related]
32. Targeted imaging of uPAR expression in vivo with cyclic AE105 variants.
Leth JM; Newcombe EA; Grønnemose AL; Jørgensen JT; Qvist K; Clausen AS; Knudsen LBS; Kjaer A; Kragelund BB; Jørgensen TJD; Ploug M
Sci Rep; 2023 Oct; 13(1):17248. PubMed ID: 37821532
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
[TBL] [Abstract][Full Text] [Related]
34. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
35. Human Glioblastoma Visualization: Triple Receptor-Targeting Fluorescent Complex of Dye, SIWV Tetra-Peptide, and Serum Albumin Protein.
An JM; Moon H; Verwilst P; Shin J; Kim BM; Park CK; Kim JS; Yeo SG; Kim HY; Kim D
ACS Sens; 2021 Jun; 6(6):2270-2280. PubMed ID: 34100604
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
[TBL] [Abstract][Full Text] [Related]
37. Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab
Polikarpov DM; Campbell DH; McRobb LS; Wu J; Lund ME; Lu Y; Deyev SM; Davidson AS; Walsh BJ; Zvyagin AV; Gillatt DA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32316186
[TBL] [Abstract][Full Text] [Related]
38. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
[TBL] [Abstract][Full Text] [Related]
39. Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumors.
Hernandez Vargas S; Lin C; Voss J; Ghosh SC; Halperin DM; AghaAmiri S; Cao HST; Ikoma N; Uselmann AJ; Azhdarinia A
J Biomed Opt; 2020 Dec; 25(12):. PubMed ID: 33300316
[TBL] [Abstract][Full Text] [Related]
40. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
